Cannara Biotech Inc.

TSXV:LOVE 株式レポート

時価総額:CA$60.3m

Cannara Biotech 過去の業績

過去 基準チェック /26

Cannara Biotechは、平均年間74.5%の収益成長を遂げていますが、 Personal Products業界の収益は、年間 成長しています。収益は、平均年間9.3% 59%収益成長率で 成長しています。 Cannara Biotechの自己資本利益率は6.5%であり、純利益率は6.9%です。

主要情報

74.5%

収益成長率

75.2%

EPS成長率

Personal Products 業界の成長35.8%
収益成長率59.0%
株主資本利益率6.5%
ネット・マージン6.9%
前回の決算情報31 May 2024

最近の業績更新

Cannara Biotech's (CVE:LOVE) Earnings May Just Be The Starting Point

Dec 18
Cannara Biotech's (CVE:LOVE) Earnings May Just Be The Starting Point

Recent updates

These 4 Measures Indicate That Cannara Biotech (CVE:LOVE) Is Using Debt Extensively

Oct 29
These 4 Measures Indicate That Cannara Biotech (CVE:LOVE) Is Using Debt Extensively

Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings

Aug 22
Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings

Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue

Aug 21
Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue

Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?

Jul 14
Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?

Cannara Biotech Inc.'s (CVE:LOVE) Prospects Need A Boost To Lift Shares

May 09
Cannara Biotech Inc.'s (CVE:LOVE) Prospects Need A Boost To Lift Shares

Here's Why We Think Cannara Biotech (CVE:LOVE) Might Deserve Your Attention Today

Feb 28
Here's Why We Think Cannara Biotech (CVE:LOVE) Might Deserve Your Attention Today

Investor Optimism Abounds Cannara Biotech Inc. (CVE:LOVE) But Growth Is Lacking

Jan 24
Investor Optimism Abounds Cannara Biotech Inc. (CVE:LOVE) But Growth Is Lacking

Cannara Biotech's (CVE:LOVE) Earnings May Just Be The Starting Point

Dec 18
Cannara Biotech's (CVE:LOVE) Earnings May Just Be The Starting Point

Is Cannara Biotech (CVE:LOVE) A Risky Investment?

Jul 29
Is Cannara Biotech (CVE:LOVE) A Risky Investment?

Cannara Biotech Inc.'s (CVE:LOVE) Business Is Yet to Catch Up With Its Share Price

Apr 10
Cannara Biotech Inc.'s (CVE:LOVE) Business Is Yet to Catch Up With Its Share Price

Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden

Jan 26
Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden

Cannara Biotech's (CVE:LOVE) Earnings Aren't As Good As They Appear

Jan 27
Cannara Biotech's (CVE:LOVE) Earnings Aren't As Good As They Appear

Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet

Dec 10
Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet

Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt

Mar 16
Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt

Can You Imagine How Cannara Biotech's (CSE:LOVE) Shareholders Feel About The -6.5% Share Price Increase?

Jan 22
Can You Imagine How Cannara Biotech's (CSE:LOVE) Shareholders Feel About The -6.5% Share Price Increase?

Have Insiders Been Buying Cannara Biotech Inc. (CSE:LOVE) Shares?

Dec 18
Have Insiders Been Buying Cannara Biotech Inc. (CSE:LOVE) Shares?

収支内訳

Cannara Biotech の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

TSXV:LOVE 収益、費用、利益 ( )CAD Millions
日付収益収益G+A経費研究開発費
31 May 24775181
29 Feb 24736171
30 Nov 23669151
31 Aug 23577141
31 May 23515131
28 Feb 23453111
30 Nov 22403111
31 Aug 22362101
31 May 22301101
28 Feb 2227191
30 Nov 2122182
31 Aug 2117-272
31 May 2111-772
28 Feb 215-1173
30 Nov 203-1383
31 Aug 203-1293
31 May 203-12112
29 Feb 202-12121
30 Nov 192-13110
31 Aug 192-12110
31 Aug 181-440

質の高い収益: LOVEにはCA$2.3M } という大きな 一回限りの 利益があり、過去 12 か月の財務実績が31st May, 2024に影響を及ぼしています。

利益率の向上: LOVEの現在の純利益率 (6.9%)は、昨年(9.5%)よりも低くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: LOVE過去 5 年間で収益を上げており、収益は年間74.5%増加しています。

成長の加速: LOVEの過去 1 年間の収益成長率 ( 9.2% ) は、5 年間の平均 ( 年間74.5%を下回っています。

収益対業界: LOVEの過去 1 年間の収益成長率 ( 9.2% ) はPersonal Products業界-5.2%を上回りました。


株主資本利益率

高いROE: LOVEの 自己資本利益率 ( 6.5% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘